v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
OPERATING EXPENSES        
General and administrative $ 2,331,283 $ 1,655,189 $ 7,624,984 $ 3,991,567
Research and development 1,492,881 305,204 4,336,576 343,206
Research and development expense- license acquired       1,046,965
TOTAL OPERATING EXPENSES 3,824,164 1,960,393 11,961,560 5,381,738
LOSS FROM OPERATIONS (3,824,164) (1,960,393) (11,961,560) (5,381,738)
OTHER INCOME (EXPENSE)        
Interest expense (1,573) (60,944) (3,226) (119,195)
Change in fair value of warrant liabilities (285,284) (13,240) (909,474) (51,942)
Loss on disposal of fixed asset     (3,230) 0
Equity in losses on equity method investment (101,238)   (218,589) 0
Other income 412,371   412,371  
Total other income (expenses), net 24,276 (74,184) (722,148) (171,137)
NET LOSS $ (3,799,888) $ (2,034,577) $ (12,683,708) $ (5,552,875)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.18) $ (0.38) $ (0.69) $ (0.96)
WEIGHTED AVERAGE SHARES OUTSTANDING:        
BASIC AND DILUTED 21,193,387 5,328,767 18,441,961 5,754,791

Source